Discovering Anti-Cancer Drugs via Computational Methods
Copyright © 2020 Cui, Aouidate, Wang, Yu, Li and Yuan..
New drug discovery has been acknowledged as a complicated, expensive, time-consuming, and challenging project. It has been estimated that around 12 years and 2.7 billion USD, on average, are demanded for a new drug discovery via traditional drug development pipeline. How to reduce the research cost and speed up the development process of new drug discovery has become a challenging, urgent question for the pharmaceutical industry. Computer-aided drug discovery (CADD) has emerged as a powerful, and promising technology for faster, cheaper, and more effective drug design. Recently, the rapid growth of computational tools for drug discovery, including anticancer therapies, has exhibited a significant and outstanding impact on anticancer drug design, and has also provided fruitful insights into the area of cancer therapy. In this work, we discussed the different subareas of the computer-aided drug discovery process with a focus on anticancer drugs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Frontiers in pharmacology - 11(2020) vom: 19., Seite 733 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cui, Wenqiang [VerfasserIn] |
---|
Links: |
---|
Themen: |
AI |
---|
Anmerkungen: |
Date Revised 28.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fphar.2020.00733 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM310881471 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM310881471 | ||
003 | DE-627 | ||
005 | 20240328235355.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fphar.2020.00733 |2 doi | |
028 | 5 | 2 | |a pubmed24n1353.xml |
035 | |a (DE-627)NLM310881471 | ||
035 | |a (NLM)32508653 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cui, Wenqiang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Discovering Anti-Cancer Drugs via Computational Methods |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 28.03.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2020 Cui, Aouidate, Wang, Yu, Li and Yuan. | ||
520 | |a New drug discovery has been acknowledged as a complicated, expensive, time-consuming, and challenging project. It has been estimated that around 12 years and 2.7 billion USD, on average, are demanded for a new drug discovery via traditional drug development pipeline. How to reduce the research cost and speed up the development process of new drug discovery has become a challenging, urgent question for the pharmaceutical industry. Computer-aided drug discovery (CADD) has emerged as a powerful, and promising technology for faster, cheaper, and more effective drug design. Recently, the rapid growth of computational tools for drug discovery, including anticancer therapies, has exhibited a significant and outstanding impact on anticancer drug design, and has also provided fruitful insights into the area of cancer therapy. In this work, we discussed the different subareas of the computer-aided drug discovery process with a focus on anticancer drugs | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a AI | |
650 | 4 | |a CADD | |
650 | 4 | |a anti-cancer | |
650 | 4 | |a computational methods | |
650 | 4 | |a drug discovery | |
700 | 1 | |a Aouidate, Adnane |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shouguo |e verfasserin |4 aut | |
700 | 1 | |a Yu, Qiuliyang |e verfasserin |4 aut | |
700 | 1 | |a Li, Yanhua |e verfasserin |4 aut | |
700 | 1 | |a Yuan, Shuguang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d 2010 |g 11(2020) vom: 19., Seite 733 |w (DE-627)NLM208568891 |x 1663-9812 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2020 |g day:19 |g pages:733 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fphar.2020.00733 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2020 |b 19 |h 733 |